Hints and tips:
...Biosimilars shot up from a 2 per cent share of all Humira prescriptions at the end of March to 19 per cent by mid-April, according to data provider IQVIA....
...of stocks such as Discovery Inc....
...This is roughly 2 per cent of the budget for all prescription medicines, according to US health data company IQVIA....
...Murray Aitken, executive director of the IQVIA Institute for Human Data Science in New Jersey, believes the question of how much health systems should pay for a drug that, however flawed, offers a rare shaft...
...China is the biggest emerging market for pharmaceuticals, forecast to reach between $145bn to $175bn in 2022, according to healthcare data firm Iqvia, compared to $137bn last year....
...Murray Aitken, executive director of the IQVIA Institute for Human Data Science, which charts pharmaceutical industry trends, said the groups looking to carve out a big slice of the biosimilars market were...
International Edition